FDA
-
-
-
-
-
-
-
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
-
-
-
-
-
-
-
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
-
-
-
-
-
-
-
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
-
-
-
-
-
-
-
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
-
-
-
-
-
-
-
Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
-
-
-
-
-
-
-
Alcon (ALC) Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength
-
-
-
-
-
-
-
Alcon Showcases Contact Lens, Eye Allergy and Dry Eye Innovations as Title Sponsor of #SECO2020
-
335,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


